Le Lézard
Classified in: Health
Subject: PER

USA Olympic and National Team Professional Goalkeeper, Shep Messing, Joins Good Pharmaceutical Development Company as They Launch PainTx


LYNBROOK, N.Y., Sept. 21, 2018 /PRNewswire/ -- Long island based Good Pharmaceutical Development Company LLC is proud to announce the appointment of Shep Messing, legendary Olympic and professional soccer goalkeeper, as the Director of Professional Athletic Affairs and Promotions.

In this role, Shep Messing will be developing an Advisory Board for the promotion and commercial development of PainTx, the most potent topical hemp derived CBD cream available today (2,200 mg, 7.5%). Mr. Messing is already in discussions with current and former professional athletes in the NFL, MLB, NBA, MLS and the NHL about joining the team. Spearheaded by Messing, the company will seek to bring the influence, prestige and experience of accomplished and professional athletes to the forefront of the conversation, helping to educate and inform Americans about safe pain relief with PainTx.

"Constant pain is an occupational hazard for professional athletes," says Shep Messing. "PainTx is the most effective and safe method for alleviating pain that I have ever seen and used."

Professional athletes are confronted by frequent injuries and acute, chronic pain that affects their health and athletic performance daily. With the introduction of PainTx, non-systemic pain relief can be achieved with the simple topical application of this non-toxic CBD cream. Until now, there has not been an adequate, effective and safe treatment available for pain relief, but today, Good Pharmaceutical Development Company is proud to be the only company in the world with clinical data to support the safety and efficacy of their hemp derived CBD product.

"We are thrilled to have Mr. Messing on board as we launch PainTx. Seeing his success with the product, and the success so many others have had after immediate application, is an exciting advancement for the future of safe pain management and symptom relief," says Dr. Larry Good, CEO and Founder of Good Pharmaceutical Development Company LLC. "As we propel forward, with the help of Shep and the Advisory Board, I know that many other athletes, and anyone else who suffers from acute, chronic pain, will benefit greatly from the use of PainTx."

Currently, Shep remains a prominent figure in NY professional sports circles and is an analyst for MSG network. His renowned career included the following:

In the context of the opioid epidemic, and a time of public health crisis in United States, the company is making an important investment with the launch of PainTx, offering safe and effective pain relief to the American public. For more information or to purchase PainTx, visit https://www.goodpharmadevco.com/.

Contact:
Dr. Larry Good
516-780-6466
[email protected]

SOURCE Good Pharmaceutical Development Company


These press releases may also interest you

at 11:30
The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 11:30
XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid...

at 11:25
Manifest Technologies, Inc., developer of an AI-powered computational neuro-imaging platform for CNS disease, today unveiled the company after completing its initial funding and partnership with a top five global pharmaceutical company. Today, over...

at 11:08
Sunwave Health, a leader in healthcare technology, proudly announces the launch of MARA, a patent-pending, innovative AI Agent designed to transform the landscape of behavioral health documentation. Since its launch on October 25, 2023, MARA has...

at 11:04
MelliCell Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $275,000 to conduct research and development (R&D) work on "Industrial Scale Technology for Drug Development in Mature Human...

at 11:00
Eagle Hill Consulting has earned another top workplace award, this time selected by The Washington Business Journal as a 2024 Best Places to Work in the extra-large sized company category. Eagle Hill also has earned multiple best workplace awards...



News published on and distributed by: